(Z)-4-(4-(1H-imidazol-1-yl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid | 1224739-86-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (Z)-4-(4-(1H-imidazol-1-yl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid
• CAS: 1224739-86-9
• 化学式: C₁₃H₁₀N₂O₄
• 分子量: 258.233
• InChiKey: RLWHWFTVQYWTJT-GHXNOFRVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.58
• 重原子数：
  19.0
• 可旋转键数：
  4.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  92.42
• 氢给体数：
  2.0
• 氢受体数：
  5.0

反应信息

• 作为产物：
  描述：

  4-氟苯乙酮 在 sodium 作用下， 以 乙醇 、 丙酮 为溶剂， 反应 3.0h， 生成 (Z)-4-(4-(1H-imidazol-1-yl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid
  参考文献：
  名称：

  新型芳基二酮酸的设计，合成和生物学评价，具有增强的抗多药耐药细菌菌株的抗菌活性

  摘要：

  由于细菌，真菌和病毒逃避用于治疗感染的已知治疗剂的能力，因此抗菌素耐药性（AMR）是全球范围内的主要健康问题。芳基二酮酸（ADK）对几种耐药菌株（包括革兰氏阳性金黄色葡萄球菌）表现出抗菌活性。我们先前的研究表明，在相同环上，苯环上邻位具有大体积烷基的ADK类似物的活性比诺氟沙星高出十倍。通过在芳香环上引入疏水性取代基对类似物进行合理的修饰，已使针对多药耐药革兰氏阳性菌株的抗菌活性提高了十倍以上。 为了阐明这种潜在的新型抗菌剂的潜在作用机理，根据文献数据和药效学相似性搜索，对有效的ADK类似物鉴定了几种细菌酶作为推定的靶标。在选择的七个细菌靶标中，最活跃的类似物与金黄色葡萄球菌之间观察到最强的有利结合相互作用脱氢角鲨烯合酶和DNA旋转酶。此外，对接结果与文献数据相结合表明，这些新型分子还可以靶向其他几种细菌酶，包括异戊二烯基转移酶和甲硫氨酸氨基肽酶。这些结果和我们具有统计意义的3D QSAR

  DOI：

  10.1016/j.ejmech.2017.10.045

文献信息

• Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof
  申请人：Freundlich Joel S.

  公开号：US20140171444A1

  公开（公告）日：2014-06-19

  The present invention provides aryl- or heteroaryl-diketo acid compounds effective to inhibit an activity of a Mycobacterial malate synthase enzyme or to inhibit a malate synthase activity in other bacteria having the enzyme. The compounds may be phenyl- naphthyl-, or thienyl-substituted diketo acids and carboxylate derivatives thereof. Also provided are methods of treating tuberculosis or other pathophysiological conditions associated with a malate synthase enzyme with the inhibitory compounds and methods of in silico design of the inhibitory compounds. In addition, the present invention provides the inhibitory compounds designed by this method. Furthermore, three-dimensional X-ray crystal structures of the Mycobacterial malate synthase complexed with the inhibitory compounds are provided. Further still a method for stabilizing an aromatic or heteroaromatic diketo acid or its prodrug or close analog in solution by derivatizing at least the ortho position on the aromatic ring is provided.

  本发明提供了芳基或杂环芳基二酮酸化合物，其能够有效抑制结核分枝杆菌苹果酸合酶酶活性或抑制其他具有该酶的细菌的苹果酸合酶活性。这些化合物可以是苯基、萘基或噻吩基取代的二酮酸和其羧酸衍生物。还提供了使用这些抑制剂治疗结核病或其他与苹果酸合酶酶相关的病理生理状况的方法以及通过计算机模拟设计这些抑制剂的方法。此外，本发明还提供了通过这种方法设计的抑制剂。此外，还提供了与抑制剂形成复合物的结核分枝杆菌苹果酸合酶的三维X射线晶体结构。还提供了一种通过在芳香环上至少衍生化邻位位置来稳定溶液中的芳香或杂环芳香二酮酸或其前药或类似物的方法。
• Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
  申请人：Freundlich Joel S.

  公开号：US20100113477A1

  公开（公告）日：2010-05-06

  The present invention provides aryl- or heteroaryl-diketo acid compounds effective to inhibit an activity of a Mycobacterial malate synthase enzyme or to inhibit a malate synthase activity in other bacteria having the enzyme. The compounds may be phenyl-naphthyl-, or thienyl-substituted diketo acids and carboxylate derivatives thereof. Also provided are methods of treating tuberculosis or other pathophysiological conditions associated with a malate synthase enzyme with the inhibitory compounds and methods of in silico design of the inhibitory compounds. In addition, the present invention provides the inhibitory compounds designed by this method. Furthermore, three-dimensional X-ray crystal structures of the Mycobacterial malate synthase complexed with the inhibitory compounds are provided. Further still a method for stabilizing an aromatic or heteroaromatic diketo acid or its prodrug or close analog in solution by derivatizing at least the ortho position on the aromatic ring is provided.
• US8664255B2
  申请人：——

  公开号：US8664255B2

  公开（公告）日：2014-03-04
• Design, synthesis and biological evaluation of novel aryldiketo acids with enhanced antibacterial activity against multidrug resistant bacterial strains
  作者：Ilija N. Cvijetić、Tatjana Ž. Verbić、Pedro Ernesto de Resende、Paul Stapleton、Simon Gibbons、Ivan O. Juranić、Branko J. Drakulić、Mire Zloh

  DOI：10.1016/j.ejmech.2017.10.045

  日期：2018.1

  evade known therapeutic agents used in treatment of infections. Aryldiketo acids (ADK) have shown antimicrobial activity against several resistant strains including Gram-positive Staphylococcus aureus bacteria. Our previous studies revealed that ADK analogues having bulky alkyl group in ortho position on a phenyl ring have up to ten times better activity than norfloxacin against the same strains. Rational

  由于细菌，真菌和病毒逃避用于治疗感染的已知治疗剂的能力，因此抗菌素耐药性（AMR）是全球范围内的主要健康问题。芳基二酮酸（ADK）对几种耐药菌株（包括革兰氏阳性金黄色葡萄球菌）表现出抗菌活性。我们先前的研究表明，在相同环上，苯环上邻位具有大体积烷基的ADK类似物的活性比诺氟沙星高出十倍。通过在芳香环上引入疏水性取代基对类似物进行合理的修饰，已使针对多药耐药革兰氏阳性菌株的抗菌活性提高了十倍以上。 为了阐明这种潜在的新型抗菌剂的潜在作用机理，根据文献数据和药效学相似性搜索，对有效的ADK类似物鉴定了几种细菌酶作为推定的靶标。在选择的七个细菌靶标中，最活跃的类似物与金黄色葡萄球菌之间观察到最强的有利结合相互作用脱氢角鲨烯合酶和DNA旋转酶。此外，对接结果与文献数据相结合表明，这些新型分子还可以靶向其他几种细菌酶，包括异戊二烯基转移酶和甲硫氨酸氨基肽酶。这些结果和我们具有统计意义的3D QSAR